Although this difference did not reach statistical significance due to the limited sample size, this observation underscores the potential influence of baseline tumour biology on long-term outcomes, even among patients with favourable pathological responses.
← all excerpts
Real-world applications of postneoadjuvant stage I of the staging system for oesophageal squamous cell cancer: what is beyond a pathological complete response?
1
—
—